News Focus
News Focus
icon url

biotech_researcher

06/03/14 9:53 AM

#49784 RE: Whosetosay #49783

2da, you may be right on that. And, thanks for the idea on eliminating the dreaded duplicated posting of messages. It only happens on iHub. I was thinking of having my "Enter" key re-worked..
icon url

lax20m

06/03/14 10:06 AM

#49785 RE: Whosetosay #49783

It wouldn't seem logical to expect efficacy to increase with lowering the dose. Lowered doses to prevent AEs is a logical approach in highly effective drugs but Rida was not highly effective.
icon url

investor maven

06/03/14 10:56 AM

#49788 RE: Whosetosay #49783

Except in the case of Ponatinib and AP26113 it's "many months" of life extension, with actually good quality of life for most patients. There are many other cnancer drugs that would fit this MD's comments (are you sure your quote is related to ARAID's drugs?) that offer only a few weeks life extention with poor quality.